An Act To Address Maine's Opiate Addiction Crisis
Maine Legislature, Session 128, LD 0565
Committee Amendment CA_A_S372 (Senate)
Amends: 22 MRSA §2353, 32 MRSA §13815

COMMITTEE AMENDMENT "f\ " to S.P. 183, L.D. 565, Bill, "An Act To 
Address Maine's Opiate Addiction Crisis" 
Amend the bill by striking out the title and substituting the following: 
'An Act Regarding the Prescribing and Dispensing of N aloxone Hydrochloride by 
Pharmacists' 
Amend the bill by striking out everything after the enacting clause and inserting the 
following: 
'Sec. 1. 22 MRSA §2353, sub-§1, ~' as enacted by PL 2015, c. 508, §1, is 
amended to read: 
D. 
11Pharmacist
means a pharmacist authorized to prescribe and dispense naloxone 
hydrochloride pursuant to Title 32, section 13815. 
Sec. 2. 22 MRSA §2353, sub-§2, ,rA-1, as enacted by PL 2015, c. 508, §2, is 
amended to read: 
A-1. 
A pharmacist may prescribe and dispense naloxone hydrochloride in 
accordance with protocols established under Title 32, section 13815 to an individual 
at risk of experiencing an opioid-related drug overdose. 
Sec. 3. 22 MRSA §2353, sub-§2, ,rA-2, as enacted by PL 2017, c. 249, §1, is 
repealed. 
Sec. 4. 22 MRSA §2353, sub-§2, ,rC-1, as enacted by PL 2015, c. 508, §2, is 
amended to read: 
C-1. 
A pharmacist may prescribe and dispense naloxone hydrochloride in 
accordance with protocols established under Title 32, section 13815 to a member of 
an individual's immediate family or a friend of the individual or to another person in a 
position to assist the individual if the individual is at risk of experiencing an opioid-
related drug overdose. 
COMMITTEE AMENDMENT 
i.,,. 
COMMITTEE AMENDMENT "A "to S.P. 183, L.D. 565 
Sec. 5. 22 MRSA §2353, sub-§2, ,fC-2, as enacted by PL 2017, c. 249, §1, is 
repealed. 
Sec. 6. 32 MRSA §13815, sub-§1, as enacted by PL 2017, c. 249, §2, is repealed. 
Sec. 7. 32 MRSA §13815, sub-§2, as enacted by PL 2017, c. 249, §2, is amended 
to read: 
2. Rules for prescribing and dispensing naloxone hydrochloride. The board by 
rule shall establish standards for authorizing pharmacists to prescribe and dispense 
naloxone hydrochloride in accordance with Title 22, section 2353, subsection 2, 
paragraphs A 2 and C 2 A-1 and C-1. 
The rules must establish adequate training 
requirements and protocols for prescribing and dispensing naloxone hydrochloride when 
there is no prescription drug order, standing order or collaborative practice agreement 
authorizing naloxone hydrochloride to be dispensed to the intended recipient. Rules 
adopted under this subsection are routine technical rules as defined in Title 5, chapter 
375, subchapter 2-A. A pharmacist authorized by the board pursuant to this subsection to 
prescribe and dispense naloxone hydrochloride may prescribe and dispense naloxone 
hydrochloride in accordance with Title 22, section 2353, subsection 2, paragraphs A4 
atl:d C 2 A-1 and C-1. 
This subsection is repealed July 1, 2019. 
Sec. 8. Maine Revised Statutes headnote amended; revision clause. In the 
Maine Revised Statutes, Title 32, chapter 117, subchapter 11-A, in the subchapter 
headnote, the words "dispensing of naloxone hydrochloride" are amended to read 
"prescribing and dispensing of naloxone hydrochloride" and the Revisor of Statutes shall 
implement this revision when updating, publishing or republishing the statutes.' 
SUMMARY 
This amendment replaces the bill, which is a concept draft. It repeals the provisions 
of Public Law 2017, chapter 249 that prevent pharmacists from prescribing and 
dispensing naloxone hydrochloride after July 1, 2019 to an individual at risk of an 
overdose or to a family member or friend of an individual at risk of an overdose. 
FISCAL NOTE REQUIRED 
(See attached) 
COMMITTEE AMENDMENT 
Fiscal Detail and Notes 
Approved: 02/14/18 feac.. 
LD 565 
LR 1847(02) 
An Act To Address Maine's Opiate Addiction Crisis 
Fiscal Note for Bill as Amended by Committee Amendment''(\' ( S -3/ iJ 
Committee: Health and Human Services 
Fiscal Note Required: Yes 
Fiscal Note 
Minor cost increase - Other Special Revenue Funds 
Additional costs to the Maine Board of Pharmacy within the Office of Professional and Occupational Regulation, 
Department of Professional and Financial Regulation, to implement the requirements of this legislation can be 
absorbed within existing budgeted resources. 
LR1847(02) - Fiscal Note - Page 1 of 1